Quinolinic acid: an endogenous inhibitor specific for type B monoamine oxidase in human brain synaptosomes
- 1 February 1987
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 74 (2) , 232-236
- https://doi.org/10.1016/0304-3940(87)90155-8
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 10 references indexed in Scilit:
- The Enzymatic Conversion of Quinolinate to Nicotinic Acid Mononucleotide in Mammalian LiverPublished by Elsevier ,2021
- Inhibition of Monoamine Oxidase by 3,4‐DihydroxyphenylserineJournal of Neurochemistry, 1986
- Quinolinic acid phosphoribosyltransferase in human and rat brain: Activity in Huntington's disease and in quinolinate-lesioned rat striatumBrain Research, 1985
- Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acidNeuroscience Letters, 1984
- Quinolinic acid, an endogenous metabolite with neurotoxic properties, alters the physical state of membrane proteins in human erythrocytesLife Sciences, 1984
- II. Excitotoxic models for neurodegenerative disordersLife Sciences, 1984
- Identification of quinolinic acid in rat and human brain tissueNeuroscience Letters, 1983
- Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat BrainScience, 1983
- Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNSEuropean Journal of Pharmacology, 1981
- Kynurenines and SeizuresEpilepsia, 1981